Sign in to continue:

Wednesday, April 1st, 2026

USBC, Inc. (USBC) Files Form 8-K Announcing Delisting Notice from NYSE American – Company Details and Filing Information




USBC, Inc. Regains NYSE American Compliance – Investor Update

USBC, Inc. Regains Compliance with NYSE American Listing Standards

Key Highlights

  • USBC, Inc. has regained full compliance with NYSE American listing standards.
  • The company has been removed from the Exchange’s list of noncompliant issuers and is no longer subject to NYSE American’s compliance plan requirements.
  • The compliance indicator “.BC” will no longer be disseminated for USBC shares.
  • USBC will continue to be subject to ongoing NYSE American listing standards and monitoring.
  • The company issued a press release on March 31, 2026, to announce this development.
  • Shareholders are reminded that if USBC fails to comply with listing standards within the next twelve months, NYSE American may take actions, including accelerated delisting.

Detailed Report

USBC, Inc. (“the Company”) announced on March 31, 2026, that the NYSE American has formally notified the Company of its successful resolution of all prior listing deficiencies. As a result, USBC is now in full compliance with the ongoing requirements for continued listing on the NYSE American exchange. Effective immediately, the Company is no longer required to adhere to a compliance plan, and the “.BC” indicator, which had previously signaled noncompliance to investors and market participants, will be removed.

The removal from the Exchange’s list of noncompliant issuers is a significant milestone for USBC, as it restores the Company’s standing and credibility in the eyes of institutional investors, analysts, and retail shareholders. This resolution may positively impact market perception and share value, as compliance with major exchange standards is often viewed as an indicator of operational and financial stability.

However, the Company and its shareholders should remain aware that USBC will be subject to the NYSE American’s ongoing listing standards and monitoring. Under Section 1009(h) of the Company Guide, if USBC fails to maintain compliance within the next twelve months, the Exchange may review the situation and could proceed with accelerated delisting procedures. This means that while the immediate risk has been mitigated, maintaining compliance remains critical to ensuring continued trading on the NYSE American.

In accordance with standard regulatory practices, the Company’s press release (Exhibit 99.1) regarding the regained compliance is being furnished and will not be deemed “filed” for purposes of Section 18 of the Securities Exchange Act of 1934. As such, it is not subject to the liabilities associated with that section, nor will it be incorporated by reference in any other filings unless expressly stated.

What Shareholders Need to Know

  • Restored Compliance Status: The company’s removal from noncompliance status may positively influence investor sentiment and share price, as it reduces the risk of delisting, which can severely impact liquidity and valuation.
  • Ongoing Compliance Monitoring: USBC must remain vigilant in adhering to NYSE American’s standards. Any future slip in compliance could trigger renewed scrutiny or even delisting.
  • Price Sensitivity: The end of the compliance indicator “.BC” may result in increased investor confidence and potentially higher trading volumes.
  • Forward-Looking Statements: The press release cautions that all forward-looking statements are subject to risks and uncertainties, including regulatory approvals, market adoption, and technological developments. Investors should consult the “Risk Factors” section of the most recent Annual Report (Form 10-K) and other SEC filings for detailed risk disclosures.
  • Contact Information: For further clarification, USBC has provided contacts for both media and investor relations in the press release.

Potential Impact on Share Value

The Company’s return to compliance is a material development that could move the share price. Removal from noncompliance status eliminates a key risk factor, potentially attracting new investors or encouraging existing shareholders to increase their holdings. However, investors should remain cognizant of the ongoing obligation to maintain compliance and the forward-looking risks outlined by management.

Exhibits

  • Exhibit 99.1: Press Release dated March 31, 2026, announcing the NYSE American notification of full compliance.
  • Exhibit 104: Cover Page Interactive Data File (embedded within the Inline XBRL document).

Disclaimer: This article is for informational purposes only and does not constitute investment advice. All forward-looking statements are subject to risks and uncertainties as disclosed in the Company’s SEC filings. Investors are advised to review official filings and consult with financial advisors before making investment decisions. The Company does not undertake any obligation to update forward-looking statements except as required by law.




View USBC, Inc. Historical chart here



Ulta Beauty 2026 Annual Report: Strategy, Growth Priorities, Loyalty Programs, and Sustainability Initiatives

Ulta Beauty, Inc. 2025 Annual Report: Key Investor Highlight...

IMUNON, Inc. Files Form 8-K with NASDAQ Listing and Company Details for March 2026

Imunon, Inc. Files Current Report on Form 8-K: Key Details f...

BioCardia, Inc. Reports 2026 Financial Results and CardiAMP Clinical Program Updates

BioCardia, Inc. Reports 2025 Financial Results and Business ...

   Ad